# Edwards Lifesciences (EW): value investors who own it

1 value investor held Edwards Lifesciences in their Q3 2026 13F, led by Wedgewood Partners. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Wedgewood Partners | 3.1% | $14.9m | Trimmed -3.4% | 12 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-08 | Lippis Daniel J. | CVP, TAVR | Sold | 619 | $53k |
| 2026-09-11 | Lippis Daniel J. | CVP, TAVR | Sold | 619 | $54k |
| 2026-08-31 | Dahl Andrew M. | SVP, Corporate Controller | Sold | 544 | $50k |
| 2026-08-28 | Bruls Annette | CVP, EMEACLA | Sold | 2644 | $238k |
| 2026-08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | Sold | 30646 | $2.8m |
| 2026-08-26 | Markowitz Wayne | CVP, JAPAC | Sold | 1240 | $113k |
| 2026-08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | Sold | 1154 | $106k |
| 2026-08-11 | Lippis Daniel J. | CVP, TAVR | Sold | 619 | $57k |
| 2026-07-30 | Markowitz Wayne | CVP, JAPAC | Sold | 146.3127 | $13k |
| 2026-07-28 | Markowitz Wayne | CVP, JAPAC | Sold | 9628 | $819k |
| 2026-07-27 | Zovighian Bernard J | CEO | Sold | 2920.5511 | $245k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/ew). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.